Risk Mitigation Strategies For Nanotechnology
Despite regulatory uncertainties and the lack of safety data, companies are rushing nanomaterials to market in a wide variety of FDA regulated product categories. A public inventory of products that claim...To view the full article, register now.
Already a subscriber? Click here to view full article